Michael C. Skaff, 10% Owner at Vivos Therapeutics, Inc. (VVOS), bought 1,353,625 shares at $1.34 ($1.8M) on 2026-03-31, disclosed to the SEC on 2026-04-02.
10% holder Michael C. Skaff executed the largest insider purchase in Vivos Therapeutics' history by buying $1.4 million of stock at $1.34. This substantial accumulation by a major shareholder signals confidence in the company's recent revenue growth and strategic positioning.
VVOS has surged 10.92% over the past five days, trading 12% below its 52-week high of $1.50 and 21.66% above its 52-week low of $1.085.
1) The largest insider purchase in company history (signal_flags.is_largest_ever). 2) Q4 2025 Earnings Call on April 16, 2026, which highlighted a 16% revenue increase.
VVOS exhibits extreme volatility with a beta of 6.21, and short interest covers 6.61% of the float, suggesting a crowded short trade.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.34 | 308,848 | $414K | 22.8% |
| 2 | $1.34 | 1,044,777 | $1.4M | 77.2% |
| Total | $1.34 avg | 1,353,625 | $1.8M | 100% |